eNOcare
Pre-clinical- Indications
- Hospital-based cardio-pulmonary conditions
Company intelligence / Profile preview
Third Pole Therapeutics
Waltham, Massachusetts, United Statespole3.com ↗
- Ownership
- Private
- Employees
- ~54
- Development stage
- Preclinical
01
Overview
Third Pole Therapeutics has developed a proprietary platform that generates inhaled nitric oxide (NO) on-demand from air and electricity. Their lead product eNOfit™—a portable device for outpatient use—has completed an early feasibility study demonstrating safety and practicality in patients with pulmonary hypertension associated with interstitial lung disease. The company’s hospital-focused device eNOcare™ targets the $600M iNO market. Both devices are investigational and not yet FDA approved but have received “breakthrough” designation for expedited review.
- Therapeutic areas
- PulmonologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Strategic equity investment from a major global medical device company to accelerate commercialization of their tankless iNO platform; specific partner not named publicly as of latest reports
Beyond the preview
Go deeper on Third Pole Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Third Pole Therapeutics.